for October 2019
NEW🔥 alarming study in CID from @CDC_NCEZID
— Antibiotic Steward (@ABsteward) October 20, 2019
Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to β-lactam antibiotics.
Would this mutation be the first first-step in developing β-lactam resistance in GAS?🤔 #IDtwitter #medtwitter https://t.co/smywt6olvC pic.twitter.com/cAp8MBaWP3
JUST RELEASED 🔥🔥🔥
— Antibiotic Steward (@ABsteward) October 9, 2019
Top New ID/Stewardship Journal Articles Link-O-Rama: October 2019https://t.co/QPmYPFPtHu
A monthly post by @IDstewardship & @ABsteward #IDTwitter #IDMedEd #IDJClub #medtwitter #MedEd #FOAMed
If you find this helpful Please RT/❤️share w others pic.twitter.com/4z8NuqmNG1
NEW🔥CID by @pharmidgirl5 @SIDPharm
— Antibiotic Steward (@ABsteward) October 1, 2019
Determining the utility of MRSA nares screening in antimicrobial stewardship. #IDTwitter https://t.co/Vsb7wHYGCp pic.twitter.com/BwO4W9ZPcH
A NEW 🔥🔥Randomized, Controlled Noninferiority 🇸🇬 Study CID
— Antibiotic Steward (@ABsteward) October 23, 2019
Early (< one week) step-down to oral antibiotics" were noninferior to Intravenous antibiotics for the early treatment of Klebsiella pneumoniae Liver Abscess. #IDTwitter https://t.co/SFbmDIwDTH pic.twitter.com/JkpHHq8GZG
NEW🔥 retrospective study in @InfectDis_Ther @SIDPharm @IDpharmresearch et Al
— Antibiotic Steward (@ABsteward) October 21, 2019
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It’s Complicated
Read full article cc @rp_mynatt#IDTwitter https://t.co/BbfpZjs6dB pic.twitter.com/AWF5jwC7vY
NEW🔥🔥 @SHEA_Epi White Paper @ICHEJournal @ASPphysician @CalderwoodMD @scottfridkin @danlivorsi @LonaMody @rebsmoe @E_Stenehjem @JulieSzymczak & @pranita_tamma
— Antibiotic Steward (@ABsteward) October 30, 2019
Research needs in antibiotic stewardship #IDTwitter #medtwitter https://t.co/8P6xIxkfNH pic.twitter.com/LPlm8VMsuG
NEW🔥🔥 in OFID @SIDPharm @krutu8 @IDstewardship @bk_HILL @Bruce_M_Jones @KisgenUF @stoverkr @blandman19 @BBookstaver_USC
— Antibiotic Steward (@ABsteward) October 15, 2019
Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2018. #IDTwitter https://t.co/SDVHIQQs0q pic.twitter.com/242zsX00uI
NEW🔥 in OFID Dr. Kollef et Al @ScottMicek
— Antibiotic Steward (@ABsteward) October 9, 2019
Pathogen-Negative Sepsis—An Opportunity for Antimicrobial Stewardship. #IDTwitter https://t.co/JwGYErFbEw pic.twitter.com/3giNFXNnKB
94.4% of 5,056 with a penicillin “allergy” tolerated repeat administration of penicillins without any adverse reactions.
— Eric Macy (@EricMacyMD) October 27, 2019
A Closer Look at Penicillin Allergy History: Systematic Review and Meta-analysis of Tolerance to Drug Challenge. - PubMed - NCBI https://t.co/HaptGMwSij
After 12 yrs of waiting, and 5 years of development, the @atscommunity @IDSAInfo community-acquired pneumonia guidelines have come out https://t.co/kqAInuix7Z. I have been asked repeatedly for my take and it has taken a while to fully dig my teeth into everything w/ a #tweetorial pic.twitter.com/Lj1NJGpIRF
— Andrew Morris (@ASPphysician) October 7, 2019
Profound paper for the fields of infection control and antimicrobial stewardship. Sample Size Estimates for Cluster-Randomized Trials in Hospital Infection Control and Antimicrobial Stewardship. @JAMANetworkOpen https://t.co/72FkbkGEDZ
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 😷 (@eliowa) October 5, 2019
NEW 🔥 Review Article in Current Opinion in Infectious Diseases Carbapenem-sparing strategy carbapenemase, treatment, and stewardship. #IDTwitter https://t.co/SC5Gb4q9Oh pic.twitter.com/7yHofzZIKN
— Antibiotic Steward (@ABsteward) October 17, 2019
Bacteria caught changing shape to evade antibiotics
— Yoni Maisel (@Primary_Immune) October 2, 2019
-1st time this phenomenon seen by researchers
_Article: https://t.co/75oGDDjCUc #SciComm #GlobalHealth #technology #OpenScience #ITRTG #microscopy
_Journal: https://t.co/Xk6v8k3p3Y #immunology #InfectiousDiseases #BigData #IoT pic.twitter.com/m8sUDTFY1O
NEW 🔥 @bmj_latest
— Antibiotic Steward (@ABsteward) October 5, 2019
Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: 🇸🇪 randomised controlled, open label, non-inferiority study. #IDTwitter #IDuptodate https://t.co/djhOIvAbPc
What's New in Infectious Diseases
— JAMA (@JAMA_current) October 6, 2019
- Metagenomic testing for viral vs bacterial infection
- New abx! Recent approvals of omadacycline, imipenem/relebactam, lefamulin
- Step-down oral therapy for select patients w endocarditis, osteomyelitishttps://t.co/HKOBqQTSum #IDWeek2019
Scientists from the National Institute of Allergy and Infectious Diseases are infecting willing subjects with influenza A (the infamous H1N1 virus) and closely monitoring their symptoms to better understand how the virus works and how to control it. https://t.co/Oi2zAjevx9
— CNN (@CNN) October 31, 2019
CAP guidelines out. 😁Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America https://t.co/fWAM3x2nh8
— Chris Destache (@dest12) October 1, 2019
NEW🔥 in #JACnews @BSACandJAC
— Antibiotic Steward (@ABsteward) October 26, 2019
Experts #pkpd @jasonroberts_pk @IDPharmacometrx
β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill.#IDTwitter https://t.co/h5E1udz6YX pic.twitter.com/C8UnYsAt5I
Inter-disciplinary, rounds-based prospective audit and feedback is associated with lower antibiotic use in general medicine.
— Brad Langford (@BRxAD) October 22, 2019
🆕 Our latest paper in @ICHEJournal https://t.co/ayAWtrDG1y #visualabstract #antimicrobialstewardship pic.twitter.com/3GDhlXgRzY
DANCE Trial Published 🔥🔥
— Antibiotic Steward (@ABsteward) October 13, 2019
NEW @CMIJournal
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomised, double-blind, placebo-controlled, non-inferiority trial. #IDTwitter https://t.co/WiTJbKs5pn pic.twitter.com/rsY52ae50y
The WRPC is pleased to invite Pharmacists to its next activity entitled:
— SPS Western Region (@SPSWRPhaclub) October 2, 2019
“ANTIMICROBIAL STEWARDSHIP PROGRAM IMPLEMENTATION“
🗓 Saturday, November 2’nd, 2019
🕰 From 09:00 AM - 01:00 PM
📍Jeddah, The Ritz-Carlton
(Al Karam 1 Hall)
For registration: https://t.co/BsjoH3oXmH pic.twitter.com/u7FSQXfPBe
New in OFID: For patients with severe #sepsis, early consultation with an ID specialist was associated with 40 percent lower mortality: https://t.co/3ltRaCdnTw #OpenForumInfectDis #IDSAJournals @TMadalineID
— IDSA (@IDSAInfo) October 31, 2019
Do we really need to dose reduce lamivudine for CrCl 30-50 mL/min? Curious what my ID Pharmacist pals think. @SIDPharm @IDPharmacist @ABsteward @BWDionne @jeffpears0n @davidwkubiak @mmPharmD https://t.co/JD9m7tbKS4
— Paul Sax (@PaulSaxMD) October 25, 2019
5 days penicillin V (4 x daily) seems to be just as effective as 10 days (3x daily) for group A streptococcal throat infection. Time to cut down duration? @AntibioticLeeds https://t.co/vnpV7rhnNH
— Jonathan Sandoe (@j_sandoe) October 10, 2019
Do you want to improve your understanding of #AntimicrobialResistance and Social Science -sign up for Future Learn #MOOC starts on #EAAD #AntibioticGuardian https://t.co/LHa7Q2f6c8 - run by some amazing people @monsey_mcleod @e_charani #StepUp @ESRC @BSACandJAC
— Susan Hopkins (@SMHopkins) October 17, 2019
Registration is now open for our FREE Antimicrobial Stewardship in Wound Management course. Learn how to recognise and manage wound infection, as well as implement control measures in your own practice https://t.co/09Bv8xwHzP
— BSAC (@BSACandJAC) October 7, 2019
Please share!! 🏥💊💉#AMR #Medstudent #Medlife
History of benign penicillin-associated rash, > 1 year ago, is sufficient to select for a direct oral penicillin challenge.
— Eric Macy (@EricMacyMD) October 27, 2019
Multicenter Australian Study to Determine Criteria for Low- and High-Risk Penicillin Testing in Outpatients. - PubMed - NCBI https://t.co/IXgTE1TATF
The measles virus doesn't just cause a high fever and nasty rash. New research shows it actually cripples victims' immune systems against other infectious agents, sometimes for years.
— WIRED (@WIRED) October 31, 2019
TL;DR Measles leaves kids vulnerable to a whole host of other diseases https://t.co/gfpfKPAg3P
Thrilled to see this publicly available @ICHEJournal: Research Needs in Antibiotic Stewardship, which sets a kind of roadmap to where antimicrobial stewardship needs to go. For finders, policy makers, researchers. https://t.co/01fhaB11jD @SHEA_Epi
— Andrew Morris (@ASPphysician) October 30, 2019
What is #AntimicrobialResistance? And how can YOU prevent it? This short video from the @MicrobioSoc answers these questions! Watch now 🦠🧫 https://t.co/frgiM16hBl#Superbugs #AMR #AntimicrobialStewardship #Bacteria #Health #Science #OneHealthEJP #PublicHealth #OneHealth
— OneHealthEJP (@OneHealthEJP) October 23, 2019
Look at #AMR from a different perspective🔎
— BSAC (@BSACandJAC) October 7, 2019
Our FREE course, Tackling Antimicrobial Resistance: A Social Science Approach, explores how different cultures, customs and habits should all be considered to help #stopsuperbugs
Registration open now! https://t.co/WKN8haMmoU
Important new @ICHEJournal article by Dr. Susan Huang et al on errors in abx transitions between 🏥s & nsg homes: https://t.co/y0nmthWpCr
— Mike Stevens (@Dr_Mike_Stevens) October 17, 2019
~1/3 transitions included an inappropriate change in abx plan (dose, duration ++)
Do we need “transition of care” stewardship? @SHEA_Epi
Antibiotic resistance to H. pylori, a deadly bacteria linked to peptic ulcer disease and gastric cancer, has more than doubled in the past 20 years. @WHO says the superbug is one of the biggest threats to the human race. https://t.co/x4bVf2lrlX #DISARMSuperbugs
— IDSA (@IDSAInfo) October 22, 2019
A NEW 🔥Quasi-experimental study in CID @TonyMoradi @nbennett04
— Antibiotic Steward (@ABsteward) October 22, 2019
found that Antibiotics use ⬇️ by 2.2 days when deploying an automated ASP best practice provider alert that prompt antibiotic deescalation when PCT<0.25 & (+) resp PCR. #IDTwitter
ASP + RDT 👏 https://t.co/RR9TqVnADY pic.twitter.com/RmpJjukdvU
Explore Antimicrobial Resistance➡️EWMA and the British Society for Antimicrobial Chemotherapy have joined forces and developed an e-learning course on #Antimicrobial Stewardship in Wound Management.
— EWMA (@EWMAwound) October 15, 2019
Sign up now➡️ https://t.co/tbk0DDmeBN
Course start: Oct 21, 2019.@BSACandJAC pic.twitter.com/xL53WR2pds
Safe to use a direct oral challenge to confirm current tolerance with a benign penicillin-associated rash more than 1 year ago. Multicenter Australian Study to Determine Criteria for Low- and High-Risk Penicillin Testing in Outpatients. - PubMed - NCBI https://t.co/ZOdZqnYFuH
— Eric Macy (@EricMacyMD) October 12, 2019
Excited for the publication in OFID of our 2018 edition of the Top Antimicrobial Stewardship Interventions on behalf of our @SERGE_45_ABX. (1/2) https://t.co/eAE7W2X4kW
— Chris Bland (@blandman19) October 15, 2019
.@JGPharmD presents nice table on therapeutic drug monitoring of azoles. would argue for posaconazole TDM even if using delayed released tablets based on these recent data: https://t.co/8YaD3XDODw #accpam19 pic.twitter.com/qHZyFzjHnR
— Erin McCreary (@ErinMcCreary) October 26, 2019
NEW🔥 in CID @ChristineMacBr1 @amandahurstMN
— Antibiotic Steward (@ABsteward) October 4, 2019
Sustainability of Handshake Stewardship: Extending a Hand Is Effective Years Later. #IDTwitter
Dr. Parker cited the study yesterday #IDWeek2019
Cc @aliciad3 https://t.co/JQRpUi0fdw pic.twitter.com/7dQexfLccI
We welcome the PBAC’s decision to amend a number of antibiotic listings on the PBS to better align with the Antibiotic Guidelines. As noted by the Dept of Health, this will support antimicrobial stewardship and assist in reducing antimicrobial resistance. https://t.co/YAWDIAuluF
— Therapeutic Guidelines (@TGLGuidelines) October 7, 2019
6th #ESPAUR report published. #AntimicrobialResistance, Prescribing and stewardship 2018-19 data https://t.co/cyE1WCdprs @SMHopkins pic.twitter.com/AiQ9xwJjTi
— Diane Ashiru, PhD (@DrDianeAshiru) October 31, 2019
Enjoyed learning more about the @ICHEJournal & @SHEA_Epi podcasts at #IDweek2019! 🔥🔥🔥 resource for anyone interested in infection prevention & antimicrobial/dxic stewardship!https://t.co/5m66hZakTi https://t.co/JSFw232lWR
— Mike Stevens (@Dr_Mike_Stevens) October 4, 2019
☑️them out & if inclined plz rate/write a review!
Our meta-analysis of RCTs found more discontinuation✋ due to ADRs (>4 folds), GI🤮 (>2.5 folds), total ADRs (~2 folds) with use of PO💊erythromycin vs clarithro.
— Antibiotic Tweets (@khalideljaaly) October 25, 2019
Many countries/clinicians still use erythro, hope we reconsider it.
Free PDF link (50 days): https://t.co/VrUV3Mq7iW https://t.co/8YETnpbOsv pic.twitter.com/z0wyDH3voU
#Measles deletes as much as 70% of an individuals preexisting antibodies to other infectious diseases. In other children, the effect may be much worse. New work out today in Science. https://t.co/Z84VOZFmET
— Michael Mina (@michaelmina_lab) October 31, 2019
NEW 🔥 #JACnews @BSACandJAC Bayesian clinical decision support-guided Vs. clinician-guided vancomycin dosing in attainment of targeted pharmacokinetic parameters in a paediatric population. #IDTwitter #pkpd https://t.co/IaT6d5apWI pic.twitter.com/SztGzi0XSB
— Antibiotic Steward (@ABsteward) October 31, 2019
By scooping the guts out of bacteria and refilling them with an expansive fluid, scientists can discover whether a microbe is structurally strong or weak, gaining insights that could help fight infectious diseases or aid studies of the microbiome. https://t.co/n0iLAn00Ma
— Stanford University (@Stanford) October 18, 2019
Vaccinations give us a real opportunity to prevent millions of deaths per year. During National Infectious Diseases Week, learn more about how to better protect yourself, your family and your community against preventable illnesses. #WhyIVaccinate https://t.co/TkIdPoESGr
— Senator Dianne Feinstein (@SenFeinstein) October 4, 2019
AUC:MIC dosing for vanco - is it time for broad scale adoption?... there are at least some that say not yet.
— Bug Pharmacist 💊🦠 Tim Gauthier (@IDstewardship) October 19, 2019
📄 https://t.co/pPkxxQkSrF new in @AJHPOfficial
🤔 What do you think? pic.twitter.com/iXbfpvCdCl
NEW 🔥 Narrative review @CMIJournal
— Antibiotic Steward (@ABsteward) October 24, 2019
Aminoglycosides for infective endocarditis:
time to say goodbye? 🤔 #IDtwitter #medtwitter https://t.co/E1dWG11DP9 pic.twitter.com/2sTXZkGzCn
‘There is increasing evidence psycho-social factors can influence antimicrobial prescribing practice in hospitals & the community, & represent potential barriers to antimicrobial stewardship interventions’ #JACNews https://t.co/gPL2YyTiXF
— BSAC (@BSACandJAC) October 8, 2019
More Evidence that E. coli strains and ESBL types differ in humans and animals. Human strains likely transmitted through Faeco-oral route not food. Better hand hygiene key. https://t.co/FglJM2Mta7
— Susan Hopkins (@SMHopkins) October 23, 2019
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.